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Induction of Neutralizing Antibodies and Immunity in Vaccinated Guinea Pigs by Cyanogen Bromide-Peptides of VP 3 of Foot-and-Mouth Disease Virus
(Accepted I2 October I976) SUMMARY The specificity of guinea pig antisera against large cyanogen bromide-cleaved peptides of the virus capsid protein VPa of foot-and-mouth disease virus type O1, strain Kaufbeuren has been characterized by double immunodiffusion, virus neutralization and protection tests. Antibodies to purified I46S particles and the cleavage peptides of VP3 showed an incomplete cross-section against VP3 peptide antigen when reacted in immunodiffusion tests, indicating that new antigenic determinants are exhibited by the peptides which are not recognized by the antiserum against the native virus proteins.
The immune response against the reduced, unfolded chain constituents of VP3 was lower in comparison to that of native virus particles but still some immunological determinants remained actively capable of inducing virus-neutralizing antibodies in immunized guinea pigs.
The protein coat of foot-and-mouth disease virus (FMDV), a member of the family Picornaviridae, is composed of the four polypeptides VP1, VP2, VPa, VP4 and a trace of the precursor protein VP0 (Talbot & Brown, I972; Vande Woude, Swaney & Bachrach, I972) . A trypsin-sensitive protein (Burroughs et al. I97 I) later identified as VP3 was found to absorb and to induce FMDV-neutralizing antibodies (Laporte et aL ~973) . More recently it was demonstrated that swine could be protected against challenge infection with virulent FMDV by vaccination with isolated, SDS-denatured VP3 of FMDV, type AI~ strain I I9 (Bachrach et al. ~975)-Furthermore, it was shown that a mixture of peptides (VPs~ and VP3b) obtained by trypsin-treatment of VP3 did not induce precipitating or neutralizing antibodies if applied to guinea pigs.
The effect of the trypsinized peptides VPa~ and VP3b suggested that the immunological determinants of VP3 are close to or may even involve arginine and/or lysine residues. We report the preparation of large peptide fragments produced from VP3 by cleavage with cyanogen bromide (CNBr) at the methionine residues and their capability to induce virusneutralizing antibodies and immunity in vaccinated guinea pigs.
The capsid protein VPa was isolated from purified I46S particles of FMDV by chromatography on CM-cellulose (Strohmaier & Adam, I975) . For cleavage by cyanogen bromide, Io mg of isolated VP3 were dissolved in I ml of 70 ~ (v/v) trifluoroacetic acid containing 50 mg CNBr. The mixture was kept for I6 h at 2o °C in the dark and the reaction was then terminated by rapid rotary evaporation at the same temperature. To remove all traces of CNBr the evaporation procedure was repeated twice. For serological analysis the dry residue was finally resuspended in PBS, containing o.I ~ SDS. For the electrophoretic analysis VP3 and the CNBr peptides were dissolved in a o.oi M-phosphate buffer, pH 7.2, containing 0"5 M-urea, o.I ~ SDS, o.I ~ 2-mercaptoethanol and IO ~ glycerol.
The electrophoresis of purified VPz in 12"5 ~ acrylamide gels showed a single polypeptide Short communications The antisera in the peripheral walls are: anti-I46S particle (anti-virion) diluted 1:4, anti-VP~, pre-serum (VP~), anti-146S particle, anti-VP3CNBr-peptide and pre-serum (VP3CNBr), respectively. The immunoprecipitation reaction was performed in 0.8 ~ agarose gels prepared in tris-HC1 buffer, pH 7"4 (O'I M-tris, Oq5 M-NaCI, IO -a M-NaN3). Antisera against 146S particles of FMDV were raised in guinea pigs following the standard procedure. For preparation of antisera against VPa or homologous CNBr peptides four doses amounting to a total of 44o and 560/zg protein, respectively, were emulsified in complete Freund's adjuvant and inoculated into guinea pigs at weekly intervals. Non-immune sera from all animals were taken for control experiments.
migrating to a position which corresponded to that of the VP3 of the I46S particles. Purified VPa treated with CNBr was cleaved to 5 peptides with mol. wt. lower than i2ooo. Electrophoresis of iodinated CNBr peptides of VP~ labelled with 1~5I by the chloramine T method revealed that the content of intact, uncleaved VP 3 in the preparation was less than o.I 700 Further separation of the large peptide fragments by electrophoretic and chromatographic. procedures is under study. For the serological analysis the antisera against purified I46S particles of FMDV O1K, isolated VPa and the corresponding CNBr peptides were examined in double immunodiffusion tests (Fig. I) . Both antisera against VP 3 and CNBr peptides were capable of reacting with the peptide fragments of VP3 and a precipitin line of identity was observed between the I46S particle, VP~ and VP3CNBr antisera, respectively. At least one additional precipitin line appeared between the CNBr peptides of VP3 and the homologous immune serum, indicating that antigenic determinants are being exposed which are not recognized by the antibodies against the immunological determinants of the native virus capsid proteins. The specificity of the serological reaction was further confirmed by examination of pre-sera and by detection of cross-reacting complement-fixing antibodies (results not shown).
Further information concerning the immunological determinants of the subviral components VPa and the corresponding CNBr peptides were obtained by virus neutralization and vaccination studies outlined in Table I . The immunological response in vaccinated guinea I" Virus neutralization tests were performed as plaque-reduction tests in Petri dishes of BHK-21 cells using Ioo p.f.u, of FMDV O1K and an overlay of Sephadex G-2oo in Eagle's MEM.
:~ For challenge infection io 4 IDs0 of FMDV strain Ot Kaufbeuren were applied subcutaneously in the/eft hind foot pad. The appearance of primary or secondary lesions (after generalization) of foot-and-mouth disease on the foot pads and oral mucosa of the immunized guinea pigs was observed until the 7th day post infection.
pigs remained relatively low although large quantities of proteins were applied. It is well established, however, that degradation of complex macromolecular antigens such as silk fibroin, serum albumin or apomyoglobin led to a significant loss of their antigenic determinants and immunopotency (Goodman, I975) . The maximum virus-neutralizing antibody titres of sera produced in guinea pigs after four injections of I Io or I4O #g protein each were between 2. 5 logs (VP3) and 2"7 logs (VP3CNBr), respectively. The immunological data from the bleedings after each injection of the CNBr digest and the control sample of intact VPa revealed concurrent increases in the antibody titres between the first and fourth antigen inoculations reaching a nearly constant level after the third antigen injection. The following virus-neutralizing antibody titres expressed as -logz0 were determined for a VP3CNBr serum during the immunization period: 0.6 (7th day), I'5 04th day), I'7 (2Ist day), 2-6 (28th day) and 2. 7 (35th day). The corresponding titres for a VP3 serum were found to be 0.6, I'9, 2"3, 2"3 and 2"5, respectively.
From these data it can be inferred that the virus-neutralizing antibody is the major response to the administration of CNBr-cleaved peptides of VP3. These observations are reinforced by further experiments in which VP3CNBr, separated from the intact VP3 by gel filtration on Sephadex G-75 and subsequently tested in antibody binding studies, was nevertheless still able to bind to antibody molecules.
The production of virus-neutralizing antibodies in guinea pigs vaccinated with large peptide fragments prompted us to expose the animals to challenge infection with pathogenic guinea pig-adapted FMDV O1K 96 days post vaccination. The results of the tests are shown in Table I . One of the guinea pigs vaccinated with CNBr-peptides developed viraemia and generalized foot lesions. The remaining animals in that group and VPa-vaccinated guinea pigs were found to be protected against the challenge infection whereas all animals of the unvaccinated control group died after viraemia and generalization.
Electrophoretic analysis and infectivity assays as well as the isolation procedures which removed all contaminating RNA showed that the immunological effect of the CNBrpeptides was due neither to uncleaved VP3 nor infectious RNA.
The capability of the CNBr-peptides of VPa to induce virus-neutralizing antibodies and at least partial immunity in vaccinated guinea pigs indicated that the specific conformation of the native virus capsid protein VP3 of FMDV within the intact virus particle is not a prerequisite condition for its immunological determinants. The non-enzymatic cleavage of VP3 under the mild conditions of CNBr-treatment offers the chance to separate single peptides and to analyse them for their immunological determinants.
